找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cosmetics; Controlled Efficacy P. Elsner,Howard I. Maibach (Professor),Hans F. Me Book 1999 Springer-Verlag Berlin Heidelberg 1999 ageing.

[復制鏈接]
樓主: 要求
41#
發(fā)表于 2025-3-28 16:10:00 | 只看該作者
Ruth McNerlan,Yaxin Bi,Guoze Zhao,Bing Han We will provide here information about the PAL, especially about those regulations related to efficacy claims for cosmetics (We use the term of efficacy simply here; however, it can also denote clinical effectiveness, usefulness and even product claims).
42#
發(fā)表于 2025-3-28 21:45:22 | 只看該作者
43#
發(fā)表于 2025-3-28 23:18:31 | 只看該作者
44#
發(fā)表于 2025-3-29 04:43:45 | 只看該作者
45#
發(fā)表于 2025-3-29 10:43:07 | 只看該作者
to Article 7b, special claims of efficacy could be legally attributed to cosmetic products but under the obligation to make evidence of the claimed effects; also an entirely new "controller" was introduced - the independent "safety assessor", This indeed means not only progress in reliable and hones
46#
發(fā)表于 2025-3-29 15:05:48 | 只看該作者
Michael Crowhurst,Michael Emslieons for its use and disposal as well as any other indication or information provided by the manufacturer or his authorized agent or by any other person responsible for placing the product on the Community market” [1].
47#
發(fā)表于 2025-3-29 16:29:39 | 只看該作者
Zhiwei Luo,Rong Xie,Wangyi Huang,Yiwei Shann Europe, for example, the European Cosmetic Directive requires that products have documentation to support the claims made [1]. In the United States the requirement is essentially the same except that some products that are considered cosmetic in some regulatory jurisdictions are over-the-counter drug products in the United States.
48#
發(fā)表于 2025-3-29 20:16:32 | 只看該作者
Siegfried Bodenmann,Anne-Lise Reyributed to wider use. As available products have proliferated in the marketplace, claims regarding performance and efficacy of self-tanning lotions have been refined and broadened for promotion to an enlarging consumer base.
49#
發(fā)表于 2025-3-30 00:11:46 | 只看該作者
50#
發(fā)表于 2025-3-30 07:38:35 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 13:05
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
邢台县| 沙雅县| 卢龙县| 怀仁县| 武川县| 阳谷县| 金门县| 辽宁省| 吕梁市| 信丰县| 米林县| 卓尼县| 彭泽县| 措美县| 阿勒泰市| 安达市| 哈巴河县| 锡林郭勒盟| 满城县| 醴陵市| 榆林市| 南岸区| 呈贡县| 永德县| 广水市| 苍南县| 达孜县| 沙坪坝区| 汝阳县| 诏安县| 麻栗坡县| 安仁县| 临江市| 麻栗坡县| 洮南市| 社旗县| 孟村| 商洛市| 祁门县| 志丹县| 宜君县|